In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase
Top Cited Papers
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (3), 231-239
- https://doi.org/10.1016/s1535-6108(04)00051-0
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsInternational Journal of Cancer, 2002
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Antisense Inhibition of IGF Receptor Expression in HaCaT Keratinocytes: A Model for Antisense Strategies in KeratinocytesAntisense and Nucleic Acid Drug Development, 2000
- The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic GrowthEndocrine Reviews, 2000
- Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinaseFEBS Letters, 1996
- Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.Journal of Clinical Investigation, 1996
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell and Developmental Biology, 1994
- Large‐scale purification and characterisation of a recombinant epidermal growth‐factor receptor protein‐tyrosine kinaseEuropean Journal of Biochemistry, 1992
- Signal transduction by receptors with tyrosine kinase activityCell, 1990